Kedudukan dalam Saham
#39158
H-CYTE, Inc. is a biopharmaceutical firm based in the United States, dedicated... H-CYTE, Inc. is a biopharmaceutical firm based in the United States, dedicated to developing and supplying a range of treatments for individuals afflicted with persistent respiratory and pulmonary diseases. The company's core strategy involves pioneering and deploying autologous cellular therapy solutions specifically for chronic lung conditions. Additionally, H-CYTE maintains a product supply agreement with Rion, LLC, focused on advancing and distributing a biologic compound designed to combat chronic obstructive pulmonary disease (COPD). Its corporate headquarters are situated in Tampa, Florida.
Harga Saham
$0.995
Disegerakkan terakhir: 2023-07-07
Perubahan (1 hari)
-0.50%
Perubahan (1 tahun)
0.00%
Perdagangan H-CYTE, Inc. (HCYT)
Harga HCYT dengan permodalan pasaran b
Modal pasaran bagi H-CYTE, Inc.(HCYT)
Modal Pasaran: $624.98K
Sehingga August 2026, H-CYTE, Inc. mempunyai modal pasaran sebanyak $624.98K. Ini menjadikan H-CYTE, Inc. syarikat ke-39158th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran H-CYTE, Inc. dari 2014 hingga 2026
HCYT berbanding dengan 5 teratas yang paling popular stocks
| Harga HCYT |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.470T
|
+875,154,789.59%
|
|
|
|
|
$4.467T
|
+714,754,850.85%
|
|
|
|
|
$4.174T
|
+667,923,733.40%
|
|
|
|
|
$3.700T
|
+592,031,782.89%
|
|
|
|
|
$2.854T
|
+456,709,785.08%
|
